Maastricht University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Maastricht University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12363
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Maastricht University (MU) is an educational service provider that offers academic programs such as bachelor degree, master and doctoral programs. The university offers postgraduate research degrees in various subjects for a range of research needs and interests. It offers programs through its faculties and schools of arts and social sciences, business and economics, health, medicine and life sciences, humanities and sciences, law, and graduate school of governance, among others. The university also offers scientific research and education services in the STEM disciplines. MU is headquartered in Maastricht, the Netherlands.

Maastricht University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Maastricht University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maastricht University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Maastricht University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maastricht University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Maastricht University, Medical Devices Deals, 2012 to YTD 2018 9
Maastricht University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Maastricht University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Glucox Biotech Enters Into Collaboration with Maastricht University 11
Basic Pharma Enters into Co-Development Agreement with Maastricht University 12
Licensing Agreements 13
Mirabilis Therapeutics Enters into Licensing Agreement with Maastricht University and Maastricht University Medical 13
Matisse Pharma Enters into Licensing Agreement with Maastricht University 14
Equity Offering 15
CiMaas Spins Out from Maastricht University Medical Center 15
Maastricht University – Key Competitors 16
Maastricht University – Key Employees 17
Maastricht University – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Other Significant Developments 19
Aug 09, 2018: New study views cancer treatment as a game to find strategies that improve patient outcomes 19
Jan 19, 2017: CiMaas starts 2017 with successful first investment 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Maastricht University, Pharmaceuticals & Healthcare, Key Facts 2
Maastricht University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maastricht University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Maastricht University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maastricht University, Deals By Therapy Area, 2012 to YTD 2018 8
Maastricht University, Medical Devices Deals, 2012 to YTD 2018 9
Maastricht University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Glucox Biotech Enters Into Collaboration with Maastricht University 11
Basic Pharma Enters into Co-Development Agreement with Maastricht University 12
Mirabilis Therapeutics Enters into Licensing Agreement with Maastricht University and Maastricht University Medical 13
Matisse Pharma Enters into Licensing Agreement with Maastricht University 14
CiMaas Spins Out from Maastricht University Medical Center 15
Maastricht University, Key Competitors 16
Maastricht University, Key Employees 17
Maastricht University, Subsidiaries 18

List of Figures
Maastricht University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Maastricht University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Maastricht University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Maastricht University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Maastricht University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maastricht University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Maastricht University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maastricht University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Maastricht University, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Maastricht University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Haier Group:企業の戦略・SWOT・財務情報
    Haier Group - Strategy, SWOT and Corporate Finance Report Summary Haier Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Sony Mobile Communications AB.:企業の戦略的SWOT分析
    Sony Mobile Communications AB. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Columbus Energy Resources PLC (CERP):石油・ガス:M&Aディール及び事業提携情報
    Summary Columbus Energy Resources PLC (Columbus Energy), formerly LGO Energy Plc is an oil and gas exploration and development company. The company acquires, explores, develops and produces oil and gas properties. It operates oil and gas assets in Trinidad including the South West Peninsula licenses …
  • Cintas Corp (CTAS):企業の財務・戦略的SWOT分析
    Cintas Corp (CTAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Power Climber Wind:企業の戦略的SWOT分析
    Power Climber Wind - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Ushdev International Limited (511736):企業の財務・戦略的SWOT分析
    Ushdev International Limited (511736) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Curemark LLC-医療機器分野:企業M&A・提携分析
    Summary Curemark LLC (Curemark) is a biopharmaceutical company that offers development of novel therapies. The company develops novel therapies to treat serious diseases for which there are limited treatment options. It provides CM-AT, CM-4612, CM-PK, CM-182, and CM-1212 drugs. Curemark’s product ca …
  • Life Insurance Corporation of India:企業の戦略的SWOT分析
    Life Insurance Corporation of India - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • MAX Resource Corp. (MXR):企業の財務・戦略的SWOT分析
    MAX Resource Corp. (MXR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Touchstone Group plc:企業の戦略的SWOT分析
    Touchstone Group plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Hitachi Construction Machinery Co., Ltd. (6305):企業の財務・戦略的SWOT分析
    Hitachi Construction Machinery Co., Ltd. (6305) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Troms Offshore Supply AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Troms Offshore Supply AS (Troms Offshore), a subsidiary of Tidewater Inc, is a offshore service provider that owns and operates offshore service vessels and other special vessels related to research and sub sea activities. The company’s fleet includes platform supply vessels, polar research …
  • Sanchez Midstream Partners LP (SPP):企業の財務・戦略的SWOT分析
    Summary Sanchez Midstream Partners LP (SMP), formerly Sanchez Production Partners LP, a subsidiary of Sanchez Oil & Gas Corp, is an oil and gas company that acquires, develops and operates midstream and other energy related assets. The company offers drilling results, production, and hedging service …
  • SOL SpA (SOL):企業の財務・戦略的SWOT分析
    Summary SOL SpA (SOL), a subsidiary of Gas and Technologies World BV, is engaged in research, produces and distributes industrial, pure, technical, and medicinal gases. The company’s technical gases include nitrogen, oxygen, hydrogen, carbon dioxide, argon, nitrous oxide, acetylene, medical gases, g …
  • Motorola Solutions, Inc.:企業の戦略・SWOT・財務情報
    Motorola Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Motorola Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Omnicom Group Inc. (OMC):企業の財務・戦略的SWOT分析
    Omnicom Group Inc. (OMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Intrexon Corp (XON)-医療機器分野:企業M&A・提携分析
    Summary Intrexon Corp (Intrexon), formerly Genomatix Corp is a provider of therapeutic solutions. The company operates through its divisions such as human therapeutics, protein production, industrial products, agricultural biotech, and animal sciences. Its human therapeutics division develops therap …
  • Bulgarian Telecommunications Company (VIVACOM):企業の戦略的SWOT分析
    Bulgarian Telecommunications Company (VIVACOM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Mitsubishi Motors Corporation:企業の戦略・SWOT・財務分析
    Mitsubishi Motors Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Motors Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Groupe Sodiaal:戦略・SWOT・企業財務分析
    Groupe Sodiaal - Strategy, SWOT and Corporate Finance Report Summary Groupe Sodiaal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆